Lung Cancer

June 12, 2017June 12, 2017

Canadian Lung Cancer Groups Call for Speedy Public Funding of New Therapies

Lung Cancer, News

Two Canadian lung cancer organizations have asked provincial government officials and the pharmaceutical industry to expedite negotiations that lead to the public funding of several new Health Canada-approved treatments. Lung Cancer ... Read more

May 12, 2017May 12, 2017

Genomic Classifiers Shown to Improve Diagnosis of Lung Cancer and IPF, Veracyte Says

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Multiple studies’ data support the use of Veracyte’s genomic classifiers to improve the diagnosis of lung cancer and idiopathic pulmonary fibrosis (IPF), the company reports. The data will be presented ... Read more

March 31, 2017March 31, 2017

Chantix is Effective, Safe Therapy to Stop Smoking, Researchers Opine

Lung Cancer, News

Chantix (varenicline) is an effective and safe therapy to quit smoking, according to researchers from the Charles E. Schmidt College of Medicine at Florida Atlantic University. The therapy ultimately could have prevented heart attacks ... Read more

January 31, 2017January 31, 2017

Anxiety, Depression May Increase Mortality Among Lung Cancer Patients

Lung Cancer, News

Patients who are diagnosed with cancer can experience significant emotional distress. Now a study has shown that anxiety and depression may increase mortality among patients who have advanced lung cancer. ... Read more

January 19, 2017January 19, 2017

New Removable Stent Shows Potential for Pulmonary Medicine

Lung Cancer, News

A new type of removable stent, created in 2015 for use in blood vessels, shows potential to also be used in the respiratory tract, which could transform treatment for patients who are ... Read more

January 9, 2017January 9, 2017

Older Patients with Non-small Cell Lung Cancer Face Significant Challenges After Treatment, Study Shows

Lung Cancer, News

Older patients with early non-small cell lung cancer (NSCLC) can spend an average of one in three days interacting with the healthcare system during the initial 60 days after treatment — either ... Read more

January 6, 2017January 6, 2017

Past Decade Saw Many New Therapies for NSCLC, but Modest Survival Benefit for Patients

Lung Cancer, News

The past decade saw the development of several new therapies for non-small cell lung cancer (NSCLC), but little survival benefit for patients with advanced-stage disease, according to a new study ... Read more

December 15, 2016December 15, 2016

LUNGevity Presents Research on Lung Cancer Treatments, Patient Preferences

Lung Cancer, News

LUNGevity Foundation, a nonprofit lung cancer organization, recently presented four of its research abstracts regarding patient preferences and treatment options were presented at this year’s International Association for the Study of Lung Cancer ... Read more

November 29, 2016November 29, 2016

Blood Test Seen to Predict Chemotherapy Response in Advanced Lung Cancer Patients

Lung Cancer, News

Scientists at the Cancer Research UK Manchester Institute found that a simple blood test may tell how well patients with small-cell lung cancer (SCLC) will respond to chemotherapy. The study, “Molecular analysis ... Read more

November 9, 2016November 9, 2016

Lung Cancer Patients Asked to Join Data Registry Aiming for Better Trials and Treatments

Lung Cancer, News

The Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association (ALA) and AltaVoice — formerly known as PatientCrossroads — recently announced the start of a joint Lung Cancer Registry to gather ... Read more